Monthly Archives: July 2013

Industry Growth Factor: Biologics

Graph

Last week, EvaluatePharma released their updated sales and R&D outlook for the drug industry in their report “World Preview 2013, Outlook to 2018”. Among the 37 pages of data, one central take home message was that growth will return to the sector after a small dip in 2012. Behind this predicted comeback in sales growth is the rise of biologics products that continue to gain a larger percentage of total revenue. Consider the data below taken from Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Untapped Potential in the Healthy Aging Marketplace

Healthy Aging Means Business

There are over 10,000 Baby Boomers entering Medicare every day and they have been instrumental in redefining the idea of aging into “healthy aging” and even further into “anti-aging.”  They are a transformational generation and their desire to stay vital is driving the growth of new medicines, products and services aimed at keeping them healthy. Almost half of all Baby Boomers say they are on a consistent search for methods to prolong their health and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Sen. Grassley Raises Concerns over 340B Program

95468934

In a memo written this week, Sen. Chuck Grassley (R-IA) responded to a recent Kaiser Health News report by asking whether 340B-eligible hospitals are ‘doing everything possible to help uninsured patients receive health care, including affordable prescription drugs.’ 340B is an important safety net program designed to help uninsured indigent patients gain greater access to prescription medicines.  While there remains a need for this safety net program, there are emerging concerns about the program in Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,